module 1 cvd in prostate cancer patients increased risks & comorbidities
Published 3 years ago • 542 plays • Length 1:07:32Download video MP4
Download video MP3
Similar videos
-
24:11
the comorbidity burden in prostate cancer
-
20:48
prevalence of cvd and assessment of cv risk in patients with prostate cancer
-
18:49
risk scoring of cvd in pca patients undergoing hormonal pca treatment
-
3:08
depression and the risk of cardiovascular disease among prostate cancer patients
-
1:04:19
eaun webinar: the effects of adt, the role of nurses and exercise in prostate cancer patient care
-
41:09
urowebinar: hormone therapy in prostate cancer who, how and when
-
1:01:53
urowebinar: parp inhibitors in prostate cancer - part 1
-
58:16
urowebinar: module 3: advances in safety in the treatment of pca
-
1:06:24
metastatic hormone sensitive prostate cancer
-
1:07:13
urowebinar: prostate cancer update: 2019-2020
-
1:18:35
urowebinar: future directions in pca management
-
59:52
urowebinar parp inhibitor in prostate cancer part iii
-
54:39
urowebinar: mri and active surveillance in prostate cancer
-
1:18:00
urowebinar: identification and management of patients with nmcrpc
-
1:04:48
relevance of 68ga psma11 in prostate cancer patient management
-
1:05:21
urowebinar: renal, bladder and prostate cancer guidelines 2021: from guidelines to real world
-
0:27
prostate cancer – african american high risk - penn state cancer institute 6a
-
0:26
can a vasectomy increase the risk of prostate cancer? penn state cancer institute
-
1:03:17
urowebinar: how to manage cvd risk in pca patience during covid 19